Quantcast

Latest Implants Stories

2014-09-15 23:09:04

In his latest article, Dr. Bryan McIntosh answers questions that many women have regarding breast augmentation procedures—who else is getting this surgery performed and why? Are my reasons shared with others? Bellevue, WA (PRWEB) September 15, 2014 Breast augmentation surgeries are often the subject of debate in our society. Speculations are made regarding who is getting breast augmentation procedures and why. At times hurtful accusations may be posed toward women that have chosen this...

2014-09-15 23:08:28

ChinaMarketResearchReports.com adds Latest Report on “China PTCA Balloon Market Investment Report, 2014-2016” to its store. Inquire before buying on this report at http://www.chinamarketresearchreports.com/contacts/inquire-before-buy.php?name=114907 Dallas, TX (PRWEB) September 15, 2014 PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations....

2014-09-15 16:28:52

No Cases of Moderate or Severe Paravalvular Aortic Regurgitation at One Year MARLBOROUGH, Mass., Sept. 15, 2014 /PRNewswire/ -- New data from the Boston Scientific (NYSE: BSX) clinical trial program of the Lotus(TM) Valve System continue to demonstrate strong performance as a less invasive treatment for patients with severe aortic stenosis who are considered high risk for surgical valve replacement. Data from the REPRISE II clinical trial confirmed safety and effectiveness out to one year,...

2014-09-15 12:27:04

Platform for Robotic Total Knee Replacement in the U.S. Grows in Popularity EAST TAUNTON, Mass., Sept. 15, 2014 /PRNewswire/ -- OMNIlife science, Inc. ("OMNI(TM)"), an established medical technology company targeting the $15 billion global hip and knee replacement device market, announces surgeons have completed over 4,000 total knee replacements in the U.S. using the OMNIPlasty(TM) technique. OMNIPlasty is a total knee replacement procedure that uses robotics, driven by the OMNI...

2014-09-15 12:26:57

- Abbott's Absorb Bioresorbable Vascular Scaffold (BVS) is a revolutionary medical device used in the heart that functions like a stent but dissolves over time ABBOTT PARK, Ill., Sept. 15, 2014 /PRNewswire/ -- Abbott announced today the start of the ABSORB IV clinical trial, which will test whether its Absorb Bioresorbable Vascular Scaffold (BVS) is more cost-effective and offers a higher quality of life than a best-in-class, permanent, metallic drug eluting stent. Absorb is the...

2014-09-15 08:28:22

MemoryShape® Implants are Backed by Unsurpassed 10-Year Clinical Data SANTA BARBARA, Calif., Sept. 15 2014 /PRNewswire/ -- Mentor Worldwide LLC, the U.S. market leader in breast aesthetics, today announced the U.S. Food and Drug Administration (FDA) has approved four additional styles of the MENTOR(®) MemoryShape(®) Breast Implants, expanding its suite of silicone breast implant products. MemoryShape(®) Implants are supported by unsurpassed 10-year prospective clinical data. With...

2014-09-14 23:02:09

Wright & Schulte LLC Is Currently Representing Plaintiffs In DePuy Pinnacle Hip Lawsuit Complaints Across The Country Who Endured Risky and Painful Revision Surgeries After Receiving DePuy’s Metal-on-Metal Hip Implant. Columbus, OH (PRWEB) September 14, 2014 A new DePuy Pinnacle hip lawsuit has been filed by Wright & Schulte LLC on behalf of a Franklin County, Ohio man who underwent hip surgery to remove a DePuy metal-on-metal hip implant. The metal-on-metal hip lawsuit filed...

2014-09-14 12:20:52

- Abbott's Absorb Bioresorbable Vascular Scaffold (BVS) is a revolutionary medical device, used in the heart, that functions like a stent but dissolves over time WASHINGTON, Sept. 14, 2014 /PRNewswire/ -- Abbott announced today positive one-year clinical results from ABSORB II, the world's first prospective, randomized, controlled trial comparing the safety and effectiveness of the dissolving Absorb heart device to Abbott's market-leading metallic XIENCE family of DES. The trial,...

2014-09-13 12:20:33

Transcatheter Valve Durability Sustained Through Five Years WASHINGTON, Sept. 13, 2014 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced the presentation of five-year clinical outcomes for inoperable patients treated in The PARTNER Trial, the world's only prospective randomized trial for transcatheter aortic valve replacement (TAVR) in patients deemed too sick for open-heart...

2014-09-12 08:24:55

From 1969 to September 5, 2014, 1,413 artificial hearts of 13 different designs have been implanted in heart failure patients. Here's an update on the state of this life-saving technology. TUCSON, Ariz., Sept. 12, 2014 /PRNewswire/ -- Cardiovascular disease, which includes heart failure, is the number one cause of death, killing more people worldwide than all cancers combined. http://photos.prnewswire.com/prnvar/20140911/145568 The need for donor hearts is growing as heart disease continues...


Latest Implants Reference Libraries

0_886104d1c1c698f3a531e056704457d5
2010-10-14 16:46:25

The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...

More Articles (1 articles) »
Word of the Day
virgule
  • A punctuation mark (/) used to separate related items of information.
  • A little rod; a twig.
This word comes from the Late Latin 'virgula,' accentual mark, a diminutive of 'virga,' rod.
Related